You are here

  • Home
  • Archive
  • Volume 2, Issue Suppl 2
  • P67. Targeted natural killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCT) – clinical application of NK cells activated by heat shock protein 70 (Hsp70)

Article metrics

Article menu

Download PDFPDF

Poster Presentation
P67. Targeted natural killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCT) – clinical application of NK cells activated by heat shock protein 70 (Hsp70)

 

Online download statistics by month:

Online download statistics by month: December 2019 to August 2024

AbstractFullPdf
Dec 2019010
Jan 2020031
Feb 2020032
Apr 2020010
May 2020020
Jun 2020051
Jul 2020031
Aug 2020010
Sep 2020060
Oct 2020020
Dec 2020011
Jan 2021011
Feb 2021010
Mar 2021010
Apr 2021030
May 2021030
Jun 2021052
Jul 20210141
Aug 20210290
Sep 20210371
Oct 20210301
Nov 20210153
Dec 2021030
Jan 2022020
Feb 2022010
Mar 2022010
Apr 2022021
May 2022060
Jun 2022051
Jul 2022020
Aug 2022011
Sep 2022031
Oct 2022020
Nov 2022062
Dec 2022050
Jan 2023030
Feb 2023060
Mar 20230250
Apr 2023011
Jul 2023041
Aug 2023030
Sep 2023030
Oct 2023001
Nov 2023031
Dec 2023080
Jan 2024030
Feb 2024070
Mar 2024080
Apr 2024030
May 2024040
Jun 2024060
Jul 2024072
Aug 2024051
Total030528